To enhance efficiency and durability of antigen presentation by DCs, we transduced hematopoietic stem-progenitor cells (HSCs) with a model tumor antigen and then transplanted the gene-modified ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback